CD274 and breast cancer: Evaluation based on clinicopathologic features showed that patients with high PD-1 and PD-L1 expressions had a significantly higher rate of TNBC (p = 0.041) (p < 0.001) and HER2+BC (p = 0.004) (p = 0.004).